Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication
about
Capsid-Targeted Viral Inactivation: A Novel Tactic for Inhibiting Replication in Viral InfectionsStructural and kinetic analysis of drug resistant mutants of HIV-1 proteaseCrystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substratesProduction of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase.Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitorstrans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activityHIV-1 Gag shares a signature motif with annexin (Anx7), which is required for virus replicationEfficient gene targeting mediated by a lentiviral vector-associated meganucleaseNanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines.The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.A switch-on mechanism to activate maize ribosome-inactivating protein for targeting HIV-infected cells.Gene therapy for HIV infections: Intracellular immunization.Extent of incorporation of HIV-1 Vpr into the virus particles is flexible and can be modulated by expression level in cells.HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription.The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr.
P2860
Q27468669-08046F52-41AF-4B4D-9705-7795512320F9Q27619254-2B2574BD-D14F-4606-BB53-FFBAE532FA79Q27747736-FE10E9AB-1D42-4451-9E51-837BCF8286CBQ33783708-337D2B61-34CA-40A1-A527-EFB90D985B8AQ33784907-CD9B65C9-A800-40E4-81CB-E241BE0FB2CCQ33787316-0AD40FAB-C057-4183-8F9A-C7E31CCC0350Q33979580-DF1C20B9-675A-4788-AEDC-F5C44DF095B4Q34331870-305B238A-48F3-4222-BEA2-8AD8AA90854AQ35059242-8E7094EF-85D2-46FF-85E9-D971C7DB41ACQ35224428-45131BD7-5AFE-4737-B102-0B97C3008B50Q38220897-FF4DE345-BF93-4764-92AC-6BE21D2FDF2EQ39079514-48278FFE-9012-4C8C-BCB8-818AA794DC5AQ39691361-65430A8D-4694-48CB-B001-20A4DDDC8D29Q40138988-D4CB6399-52D7-4F1B-BE1D-7748BA6EF33FQ40894393-E93A71FD-A305-4096-A0F7-E021D3B9B990Q40928419-641FFD7B-BBDA-41FF-A377-B7F3AFD14C40Q42459014-A1BE8737-1188-44D8-A90D-BA21EE5B61CDQ43999827-4DDD13FE-B5C9-47B1-96EB-CA8D9EB8648A
P2860
Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Development of a novel anti-HI ...... residues on virus replication
@ast
Development of a novel anti-HI ...... residues on virus replication
@en
type
label
Development of a novel anti-HI ...... residues on virus replication
@ast
Development of a novel anti-HI ...... residues on virus replication
@en
prefLabel
Development of a novel anti-HI ...... residues on virus replication
@ast
Development of a novel anti-HI ...... residues on virus replication
@en
P2093
P2860
P356
P1476
Development of a novel anti-HI ...... residues on virus replication
@en
P2093
A Srinivasan
H Koprowski
V S Kalyanaraman
P2860
P304
P356
10.1073/PNAS.94.7.3346
P407
P577
1997-04-01T00:00:00Z